tradingkey.logo
tradingkey.logo
Pesquisar

Labcorp Holdings Inc

LH
Adicionar à lista de desejos
322.345USD
-2.515-0.77%
Horário de mercado 09/09, 09:33ET
26.08BValor de mercado
28.36P/L TTM

Mais detalhes de Labcorp Holdings Inc Empresa

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.

Labcorp Holdings Inc Perfil

Código da empresaLH
Nome da EmpresaLabcorp Holdings Inc
Data de listagemApr 24, 1991
CEOSchechter (Adam H)
Número de funcionários70000
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 24
Endereço358 S Main St
CidadeBURLINGTON
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal27215
Telefone13362291127
Sitehttps://www.labcorp.com/
Código da empresaLH
Data de listagemApr 24, 1991
CEOSchechter (Adam H)

Executivos da empresa Labcorp Holdings Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
102.56K
-4.55%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Biopharma Laboratory Services and Chief Medical and Scientific Officer
Executive Vice President, President, Biopharma Laboratory Services and Chief Medical and Scientific Officer
36.49K
+17.78%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+8.75%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
15.04K
+56.95%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
13.78K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
13.74K
--
Ms. Amy B. Summy
Ms. Amy B. Summy
Executive Vice President, Chief Marketing Officer
Executive Vice President, Chief Marketing Officer
6.96K
-13.29%
Ms. Kerrii B. Anderson
Ms. Kerrii B. Anderson
Independent Director
Independent Director
6.85K
-43.79%
Mr. Bryan T. Vaughn
Mr. Bryan T. Vaughn
Executive Vice President - Diagnostics
Executive Vice President - Diagnostics
6.75K
--
Ms. Sandra Dillard van Der Vaart
Ms. Sandra Dillard van Der Vaart
Executive Vice President, Chief Legal Officer, and Corporate Secretary
Executive Vice President, Chief Legal Officer, and Corporate Secretary
5.82K
+62.94%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
102.56K
-4.55%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Biopharma Laboratory Services and Chief Medical and Scientific Officer
Executive Vice President, President, Biopharma Laboratory Services and Chief Medical and Scientific Officer
36.49K
+17.78%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+8.75%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
15.04K
+56.95%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
13.78K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
13.74K
--

Perguntas frequentes

Quem são os cinco principais acionistas de Labcorp Holdings Inc?

Os cinco principais acionistas de Labcorp Holdings Inc são: Mr. Adam H. Schechter

Quantas instituições possuem ações da Labcorp Holdings Inc (LH)?

Em 2026Q1, 1855 instituições possuíam ações da Labcorp Holdings Inc, com valor de mercado aproximado de 88.74M, representando 108.22% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 5570263.00.
tradingkey.logo
Aviso de risco: Nosso site e aplicativo móvel fornecem apenas informações gerais sobre determinados produtos de investimento. A Finsights não oferece, e o fornecimento de tais informações não deve ser interpretado como se a Finsights estivesse oferecendo, aconselhamento financeiro ou recomendação para qualquer produto de investimento.
Os produtos de investimento estão sujeitos a riscos significativos, incluindo a possível perda do valor investido e podem não ser adequados para todos. O desempenho passado dos produtos de investimento não é indicativo de seu desempenho futuro.
A Finsights pode permitir que anunciantes ou afiliados realizem, ou forneçam anúncios em nosso site, ou aplicativo móvel, ou em qualquer parte deles e pode ser compensada por eles com base em sua interação com os anúncios.
 © Copyright: FINSIGHTS MEDIA PTE. LTD. Todos os direitos reservados.